מתוטרקסאט "אבווה" 10 מ"ג/מ"ל

Maa: Israel

Kieli: heprea

Lähde: Ministry of Health

Aktiivinen ainesosa:

METHOTREXATE 10 MG/ML

Saatavilla:

PHARMALOGIC LTD

ATC-koodi:

L01BA01

Lääkemuoto:

SOLUTION FOR INJECTION

Antoreitti:

I.M, I.V, INTRA-ARTERIAL, INTRATHECAL, INTRA VENTRICULAR, S.C

Valmistaja:

EBEWE PHARMA GES.M.B.H NFG.KG, AUSTRIA

Terapeuttinen ryhmä:

METHOTREXATE

Käyttöaiheet:

Antineoplastic chemotherapy: treatment of gestational choriocarcinoma, chorioadenoma destruents and hydatidiform mole. Palliation of acute lymphocytic leukemia. In the treatment and prophylaxis of meningeal leukemia. Greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukemias in children. In combination with other anticancer agents, Methotrexate may be used for the induction of remission, but is most commonly used in maintenance of induced remissions. Abitrexate may be used alone or in combination with other antineoplastics in the management of breast cancer, epidermoid cancers of the head and neck, lung cancer (particularly squamous cell and small cell types), bladder cancer and osteogenic cancer. Methotrexate is effective in the treatment of the advanced stages (III and IV Peter's Staging System) of lymphosarcoma, particularly in children, and in advanced cases of mycosis fungoides. Psoriasis: because of the high risk attending its use, Methotrexate is indicated only in the

Valtuutus päivämäärä:

2013-09-01